HA
ProgramHERA medical countermeasures for CBRN threats – Medicinal products
Funds R&D on vaccines and drugs that protect against chemical, biological, radiological and nuclear threats.
About
This is a single-stage EU4Health Project Grant with an indicative topic budget of €18 million, part of a wider HERA Action Grants call worth over €30 million across four related topics. Applications go through the EU Funding & Tenders Portal, with page-limit, eligibility and financial-capacity rules set out in the call document.
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.